NASDAQ:AGRX - Agile Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.57 -0.02 (-1.26 %)
(As of 03/20/2019 03:07 PM ET)
Previous Close$1.59
Today's Range$1.57 - $1.65
52-Week Range$0.23 - $3.01
Volume28,367 shs
Average Volume960,067 shs
Market Capitalization$67.84 million
P/E Ratio-2.69
Dividend YieldN/A
Beta0.36

Headlines

Agile Therapeutics (NASDAQ AGRX) News Headlines

Source:
DateHeadline
Agile Therapeutics Inc Expected to Post Q1 2019 Earnings of ($0.11) Per Share (AGRX)Agile Therapeutics Inc Expected to Post Q1 2019 Earnings of ($0.11) Per Share (AGRX)
www.americanbankingnews.com - March 18 at 1:33 AM
Agile Therapeutics Inc (AGRX) Forecasted to Post Q1 2020 Earnings of ($0.12) Per ShareAgile Therapeutics Inc (AGRX) Forecasted to Post Q1 2020 Earnings of ($0.12) Per Share
www.americanbankingnews.com - March 16 at 3:44 AM
Short Interest in Agile Therapeutics Inc (AGRX) Decreases By 24.9%Short Interest in Agile Therapeutics Inc (AGRX) Decreases By 24.9%
www.americanbankingnews.com - March 16 at 1:26 AM
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA CongressAgile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
finance.yahoo.com - March 15 at 8:30 AM
Agile Therapeutics Inc (AGRX) to Post Q1 2019 Earnings of ($0.10) Per Share, William Blair ForecastsAgile Therapeutics Inc (AGRX) to Post Q1 2019 Earnings of ($0.10) Per Share, William Blair Forecasts
www.americanbankingnews.com - March 15 at 7:35 AM
AGRX: Numerous Catalysts in 2019…AGRX: Numerous Catalysts in 2019…
finance.yahoo.com - March 14 at 7:20 PM
Agile Therapeutics Inc Forecasted to Post Q1 2020 Earnings of ($0.12) Per Share (AGRX)Agile Therapeutics Inc Forecasted to Post Q1 2020 Earnings of ($0.12) Per Share (AGRX)
www.americanbankingnews.com - March 14 at 8:03 AM
Agile Therapeutics (AGRX) Releases  Earnings ResultsAgile Therapeutics (AGRX) Releases Earnings Results
www.americanbankingnews.com - March 13 at 9:36 AM
Agile Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsAgile Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 12 at 10:49 PM
Agile Therapeutics: 4Q Earnings SnapshotAgile Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 12 at 10:49 PM
Agile Therapeutics Inc (AGRX) Expected to Announce Earnings of -$0.13 Per ShareAgile Therapeutics Inc (AGRX) Expected to Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - March 12 at 8:45 AM
Agile Therapeutics to Present at Upcoming Investor ConferencesAgile Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - March 11 at 7:42 PM
Agile Therapeutics up 21% on $7.8M capital raiseAgile Therapeutics up 21% on $7.8M capital raise
seekingalpha.com - March 4 at 8:00 PM
Agile Therapeutics Announces $7.8 Million Private PlacementAgile Therapeutics Announces $7.8 Million Private Placement
finance.yahoo.com - March 4 at 7:37 AM
Agile Therapeutics: Positive Study Moves Company Closer To NDA ResubmissionAgile Therapeutics: Positive Study Moves Company Closer To NDA Resubmission
seekingalpha.com - February 13 at 6:38 PM
AGRX: Positive Results for Twirla® Adhesion Study; NDA Resubmission in 2Q19AGRX: Positive Results for Twirla® Adhesion Study; NDA Resubmission in 2Q19
finance.yahoo.com - February 12 at 7:16 PM
Agile on Move after TestsAgile on Move after Tests
www.baystreet.ca - February 11 at 6:45 PM
Agile up 22% on positive Twirla dataAgile up 22% on positive Twirla data
seekingalpha.com - February 11 at 8:51 AM
Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®
finance.yahoo.com - February 11 at 8:51 AM
Agile Therapeutics to Present at the 2019 BIO CEO and Investor Conference - NasdaqAgile Therapeutics to Present at the 2019 BIO CEO and Investor Conference - Nasdaq
www.nasdaq.com - February 7 at 6:43 PM
Agile Therapeutics to Present at the 2019 BIO CEO and Investor ConferenceAgile Therapeutics to Present at the 2019 BIO CEO and Investor Conference
finance.yahoo.com - February 7 at 8:20 AM
Agile Therapeutics: Why You Should Buy Now Before Upcoming CatalystsAgile Therapeutics: Why You Should Buy Now Before Upcoming Catalysts
seekingalpha.com - January 23 at 6:27 PM
The Daily Biotech Pulse: Agile (NASDAQ:AGRX) Gives Regulatory Update On Contraceptive Patch, Advaxis (NASDAQ:ADXS) Misses Estimates, Ocular (NASDAQ:OCUL) Submits sNDA - BenzingaThe Daily Biotech Pulse: Agile (NASDAQ:AGRX) Gives Regulatory Update On Contraceptive Patch, Advaxis (NASDAQ:ADXS) Misses Estimates, Ocular (NASDAQ:OCUL) Submits sNDA - Benzinga
www.benzinga.com - January 12 at 5:34 PM
AGRX: Twirla® Adhesion Study Underway; NDA Resubmission in 2Q19…AGRX: Twirla® Adhesion Study Underway; NDA Resubmission in 2Q19…
finance.yahoo.com - January 11 at 6:40 PM
Agile Therapeutics advancing Twirla, to refile U.S. marketing application next quarterAgile Therapeutics advancing Twirla, to refile U.S. marketing application next quarter
seekingalpha.com - January 10 at 6:06 PM
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash GuidanceAgile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
finance.yahoo.com - January 10 at 6:06 PM
Agile Therapeutics to Present at Biotech Showcase 2019Agile Therapeutics to Present at Biotech Showcase 2019
finance.yahoo.com - December 18 at 8:20 AM
Agile meets with FDA on design of study to support Twirla refilingAgile meets with FDA on design of study to support Twirla refiling
seekingalpha.com - December 13 at 5:42 PM
Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
finance.yahoo.com - December 13 at 5:42 PM
Wainwright bullish on Agile Therapeutics, sees 270% upsideWainwright bullish on Agile Therapeutics, sees 270% upside
seekingalpha.com - November 29 at 5:46 PM
Agile Therapeutics Inc (NASDAQ:AGRX): Are Analysts Optimistic?Agile Therapeutics Inc (NASDAQ:AGRX): Are Analysts Optimistic?
finance.yahoo.com - November 13 at 5:12 PM
AGRX: Awaiting Details of Adhesion Study for Twirla®…AGRX: Awaiting Details of Adhesion Study for Twirla®…
finance.yahoo.com - November 5 at 5:24 PM
Form 10-Q AGILE THERAPEUTICS INC For: Sep 30Form 10-Q AGILE THERAPEUTICS INC For: Sep 30
www.streetinsider.com - November 4 at 8:22 AM
Agile Therapeutics: 3Q Earnings SnapshotAgile Therapeutics: 3Q Earnings Snapshot
finance.yahoo.com - November 2 at 8:14 AM
Agile Therapeutics Reports Third Quarter 2018 Financial ResultsAgile Therapeutics Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 1 at 6:04 PM
Late-stage data support use of Agiles Twirla in overweight women; shares up 8% premarketLate-stage data support use of Agile's Twirla in overweight women; shares up 8% premarket
seekingalpha.com - October 25 at 5:32 PM
Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the ...Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the ...
globenewswire.com - October 25 at 8:19 AM
Agile Therapeutics (AGRX) Highlights Additional Analyses of AG200-15 (Twirla) Phase 3 SECURE Study ResultsAgile Therapeutics (AGRX) Highlights Additional Analyses of AG200-15 (Twirla) Phase 3 SECURE Study Results
www.streetinsider.com - October 24 at 5:07 PM
Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)
finance.yahoo.com - October 24 at 8:20 AM
Agile Therapeutics Gets a Path Forward for Twirla, Analysts Review and TargetAgile Therapeutics Gets a Path Forward for Twirla, Analysts Review and Target
finance.yahoo.com - October 22 at 5:22 PM
Todays Research Reports on Trending Tickers: Agile Therapeutics and Horizon PharmaToday's Research Reports on Trending Tickers: Agile Therapeutics and Horizon Pharma
finance.yahoo.com - October 10 at 5:02 PM
AGRX: FDA Provides Path to NDA Resubmission for Twirla®…AGRX: FDA Provides Path to NDA Resubmission for Twirla®…
finance.yahoo.com - October 10 at 5:02 PM
Agile Therapeutics (AGRX) Completes Formal Dispute Resolution Process with the FDAAgile Therapeutics (AGRX) Completes Formal Dispute Resolution Process with the FDA
www.streetinsider.com - October 10 at 8:17 AM
Agile Therapeutics up 62% on development path for TwirlaAgile Therapeutics up 62% on development path for Twirla
seekingalpha.com - October 9 at 4:57 PM
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDAAgile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
finance.yahoo.com - October 9 at 8:23 AM
AGRX Sep 2018 7.500 callAGRX Sep 2018 7.500 call
finance.yahoo.com - September 18 at 4:59 PM
Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?
finance.yahoo.com - September 14 at 5:00 PM
Agile Therapeutics up 55% premarketAgile Therapeutics up 55% premarket
seekingalpha.com - September 11 at 4:55 PM
Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance IndicationsConsolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications
finance.yahoo.com - August 29 at 8:27 AM
AGRX: Formal Dispute Resolution Continues to Office of New Drugs…AGRX: Formal Dispute Resolution Continues to Office of New Drugs…
finance.yahoo.com - August 9 at 6:03 PM
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: Liquidity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel